Biomarin Pharmaceutical Inc. - Registered Shares

Biomarin Pharmaceutical Inc. - Registered Shares


Market Cap$15.82B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Biomarin Pharmaceutical Inc. - Registered SharesBiomarin Pharmaceutical Inc. - Registered Shares770%-6.5-

Current Fair Value

89.5% downside

Overvalued by 89.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$15.82 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$1.07
Outstanding Shares189,879,803
Avg 30 Day Volume2,952,035


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio77.02
Price to Sales6.51
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income0
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Biomarin Pharmaceutical Inc.

CEO: Jean-Jacques Bienaime